MAPLE GROVE, Minn., April 25, 2016 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith) announced that ANDROXY™ (Fluoxymesterone Tablets, USP) CIII are available for prescription. Upsher-Smith is the exclusive supplier of fluoxymesterone tablets in the United States. The medication is available as 10 mg tablets in 100-count bottles.
"As the only supplier of fluoxymesterone tablets in the United States, we have made it a priority to get this medication back on the market," said Rusty Field, President, Upsher-Smith. "We are pleased that physicians and patients can once again access ANDROXY™."
The NDC number for ANDROXY™ (Fluoxymesterone Tablets, USP) CIII in 100-count bottles is 0832-0086-00. To learn more about ANDROXY™, please see Full Prescribing Information or visit www.upsher-smith.com. For questions about ordering ANDROXY™, please call Upsher-Smith at 1-800-654-2299.
Upsher-Smith Laboratories, Inc., founded in 1919, is a growing, fully integrated pharmaceutical company dedicated to its mission of delivering high-value, high-quality therapies and solutions which measurably improve individuals' lives. As a family-owned pharmaceutical company, we are able to adapt and thrive in a dynamic healthcare environment. Our world is constantly evolving, and we are continually adapting to the ever-changing needs of patients, physicians, pharmacists, and healthcare organizations. Where there is a need, we will work to deliver solutions that simplify access to treatment, deliver better health outcomes, and enhance life. Upsher-Smith has a particular focus on developing therapies for people living with central nervous system (CNS) conditions, such as seizure disorders. For more information, visit www.upsher-smith.com.
SOURCE Upsher-Smith Laboratories, Inc.